Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

321
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
321
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

660
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
660
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.4K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.4K
Methods of Medium Optimization01:28

Methods of Medium Optimization

45
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
45
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

395
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
395

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sante publique (Vandoeuvre-les-Nancy, France)·2026
Same author

Mast cells act as pro-angiogenic and pro-tumorigenic players in pituitary gonadotroph tumors.

Neuro-oncology·2025
Same author

Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis.

Bioanalysis·2024
Same author

Assessment of matrix effect in quantitative LC-MS bioanalysis.

Bioanalysis·2024
Same author

Professional practices of dentists and unscheduled dental care in Nouvelle-Aquitaine (France)

Sante publique (Vandoeuvre-les-Nancy, France)·2024
Same author

Differentiation is accompanied by a progressive loss in transcriptional memory.

BMC biology·2024
Same journal

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress
05:22

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress

Published on: July 29, 2022

4.1K

Modeling overdispersion heterogeneity in differential expression analysis using mixtures.

Elisabetta Bonafede1, Franck Picard2, Stéphane Robin3,4

  • 1Department of Statistical Sciences, University of Bologna, 40126 Italy. elisabetta.bonafede@unibo.it.

Biometrics
|December 20, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces a novel mixture model for analyzing gene expression data from next-generation sequencing. The method improves the detection of differentially expressed genes while maintaining accurate error rates, outperforming existing approaches.

Keywords:
Differential expression analysisMixture modelsRNA-Seq dataROC/AUCType-I error

More Related Videos

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

42.7K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.3K

Related Experiment Videos

Last Updated: Mar 28, 2026

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress
05:22

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress

Published on: July 29, 2022

4.1K
Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

42.7K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.3K

Area of Science:

  • Bioinformatics
  • Statistical Genetics
  • Computational Biology

Background:

  • Next-generation sequencing (NGS) is crucial for gene expression measurement, using read counts often modeled by negative binomial distributions.
  • Accurate estimation of the overdispersion parameter is challenging due to limited replicates, impacting differential expression analysis.
  • Current methods using plug-in estimates can lead to uncontrolled Type I errors in differential analysis.

Purpose of the Study:

  • To develop a robust statistical framework for differential gene expression analysis in RNA-Seq data.
  • To address the issue of unreliable overdispersion parameter estimation in count-based models.
  • To improve the sensitivity and Type I error control of differential expression detection.

Main Methods:

  • Proposed a mixture model enabling information sharing among genes with similar variability.
  • Developed three novel statistical tests for differential expression analysis within the mixture model framework.
  • Validated the method through extensive simulations and application to prostate cancer RNA-Seq data.

Main Results:

  • The proposed mixture model achieves nominal Type I error rates.
  • Demonstrated improved sensitivity in detecting differentially expressed genes compared to common procedures.
  • The method maintains high discriminative power, effectively distinguishing between differentially and non-differentially expressed genes.

Conclusions:

  • The novel mixture model offers a statistically sound and powerful approach for RNA-Seq differential expression analysis.
  • This method enhances the reliability of identifying gene expression changes, crucial for biological and clinical insights.
  • The approach provides a valuable tool for researchers working with NGS gene expression data, particularly in cancer research.